Abklärung, Bildgebung und Differenzialdiagnose bei Myokarditis^[*]

Abstract

Myocarditis represents an important cause in the aetiology of dilative cardiomyopathy and pathogenesis of sudden cardiac death. It frequently results from cardiotropic viral infection followed by inflammatory myocardial destruction. Endomyocardial biopsy is still considered the gold standard in diagnosing myocarditis. During clinical work-up, however, diagnosis is often presumed depending on clinical presentation and non-invasive diagnostic test results. In this regard, cardiac magnetic resonance is particularly important as it offers various techniques to detect inflammatory alterations of the myocardium.

• Literatur

• 1 Kindermann I, Barth C, Mahfoud F et al. Update on myocarditis. J Am Coll Cardiol 2012; 59: 779-792
• 2 Kyto V, Saraste A, Voipio-Pulkki LM et al. Incidence of fatal myocarditis: a population-based study in Finland. Am J Epidemiol 2007; 165: 570-574
• 3 Felker GM, Thompson RE, Hare JM et al. Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy. N Engl J Med 2000; 342: 1077-1084
• 4 Kandolf R. Virus etiology of inflammatory cardiomyopathy. Dtsch Med Wochenschr 2004; 129: 2187-2192
• 5 Caforio AL, Pankuweit S, Arbustini E et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 4006-2648 , 2648a – 2648d
• 6 Pollack A, Kontorovich AR, Fuster V et al. Viral myocarditis-diagnosis, treatment options, and current controversies. Nat Rev Cardiol 2015; 12: 670-680
• 7 D’Ambrosio A, Patti G, Manzoli A et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001; 85: 499-504
• 8 Kühl U, Pauschinger M, Seeberg B et al. Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction. Circulation 2005; 112: 1965-1970
• 9 Maisch B, Richter A, Sandmoller A et al. Inflammatory dilated cardiomyopathy (DCMI). Herz 2005; 30: 535-544
• 10 Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006; 113: 593-595
• 11 Mason JW, O’Connell JB, Herskowitz A et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333: 269-275
• 12 Hufnagel G, Pankuweit S, Richter A et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 2000; 25: 279-285
• 13 Lieberman EB, Hutchins GM, Herskowitz A et al. Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991; 18: 1617-1626
• 14 McCarthy RE, Boehmer JP, Hruban RH et al. Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis. N Engl J Med 2000; 342: 690-695
• 15 Dec Jr GW, Waldman H, Southern J et al. Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol 1992; 20: 85-89
• 16 Angelini A, Calzolari V, Calabrese F et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart 2000; 84: 245-250
• 17 Herskowitz A, Campbell S, Deckers J et al. Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy. Am J Cardiol 1993; 71: 982-986
• 18 Lauer B, Niederau C, Kuhl U et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997; 30: 1354-1359
• 19 Smith SC, Ladenson JH, Mason JW et al. Elevations of Cardiac Troponin I Associated With Myocarditis: Experimental and Clinical Correlates. Circulation 1997; 95: 163-168
• 20 Morgera T, Di Lenarda A, Dreas L et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J 1992; 124: 455-467
• 21 Friedrich MG, Marcotte F. Cardiac magnetic resonance assessment of myocarditis. Circ Cardiovasc Imaging 2013; 6: 833-839
• 22 Shanes JG, Ghali J, Billingham ME et al. Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 1987; 75: 401-405
• 23 Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clinic Proceedings 1989; 64: 1235-1245
• 24 Chow LH, Radio SJ, Sears TD et al. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989; 14: 915-920
• 25 Cooper LT, Baughman KL, Feldman AM et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007; 116: 2216-2233
• 26 Mahrholdt H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004; 109: 1250-1258
• 27 Alfakih K, Reid S, Jones T et al. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol 2004; 14: 1813-1822
• 28 Friedrich MG, Sechtem U, Schulz-Menger J et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009; 53: 1475-1487
• 29 Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA 2011; 306: 277-286
• 30 Luetkens JA, Homsi R, Sprinkart AM et al. Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging 2016; 17: 154-161
• 31 Luetkens JA, Doerner J, Thomas DK et al. Acute Myocarditis: Multiparametric Cardiac MR Imaging. Radiol 2014; 273: 383-392
• 32 Cummings KW, Bhalla S, Javidan-Nejad C et al. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics : a review publication of the Radiological Society of North America, Inc 2009; 29: 89-103
• 33 Huber A, Bauner K, Wintersperger BJ et al. Phase-sensitive inversion recovery (PSIR) single-shot TrueFISP for assessment of myocardial infarction at 3 tesla. Invest Radiol 2006; 41: 148-153
• 34 Luetkens JA, Homsi R, Dabir D. Comprehensive Cardiac Magnetic Resonance for Short-Term Follow-Up in Acute Myocarditis. J Am Heart Assoc 2016; 5: e003603
• 35 Zagrosek A, Abdel-Aty H, Boye P et al. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovascular Imaging 2009; 2: 131-138
• 36 Sprinkart A, Luetkens J, Traber F et al. Gradient Spin Echo (GraSE) imaging for fast myocardial T2 mapping. J Cardiovasc Magn Resonance 2015; 17: 12
• 37 Messroghli DR, Radjenovic A, Kozerke S et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004; 52: 141-146
• 38 Radunski UK, Lund GK, Stehning C et al. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging 2014; 7: 667-675
• 39 Lurz P, Luecke C, Eitel I et al. Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. J Am Coll Cardiol 2016; 67: 1800-1811
• 40 Moon J, Messroghli D, Kellman P et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Resonance 2013; 15: 92
• 41 Hsiao JF, Koshino Y, Bonnichsen CR et al. Speckle tracking echocardiography in acute myocarditis. Int J Cardiovasc Imaging 2013; 29: 275-284
• 42 Emrich T, Emrich K, Abegunewardene N et al. Cardiac MR enables diagnosis in 90 % of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries. Br J Radiol 2015; 88: 20150025